Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Pierluigi Porcu"'
Autor:
Pierluigi Porcu, Emily Correia, Neda Nikbakht, Joya Sahu, Jisun Cha, Megan O'Donnell, Shalini Krishnasamy, Wenyin Shi, Romsin Zaya, Seyfettin Onder Alpdogan
Publikováno v:
Journal of the American Academy of Dermatology. 86:1285-1292
Background Mycosis fungoides with large-cell transformation (MF-LCT) is associated with an aggressive clinical course, yet data comparing treatment outcomes in MF-LCT are sparse. Objective To compare treatment outcomes and to determine disease preval
Autor:
Felipe Suarez, Hun Ju Lee, Cliona M. Rooney, Daniel Y Lee, Helen E. Heslop, Hye Jin Kang, Dok Hyun Yoon, Shannon Inman, Kirit M. Ardeshna, Cheolwon Suh, Pierluigi Porcu, Katherin E Combs, Seok Jin Kim, Arnaud Jaccard, Ranjana H. Advani, Yasuhiro Oki, Catherine M. Bollard, Yi Lin, Jin Seok Kim, Eric D. Jacobsen, Maryann Murray, Kurt C. Gunter, Emmanuel Bachy, John Radford, Jonathan E. Brammer, Jia Ruan, Lihua E. Budde, Sang Eun Yoon, Won Seog Kim
Publikováno v:
Annals of Hematology. 100:2529-2539
We conducted a phase II clinical trial to develop an autologous EBV-specific T cell product (baltaleucel T) for advanced, relapsed ENKTL. Among 47 patients who provided whole blood starting material for manufacturing the product, 15 patients received
Autor:
Doaa Shalabi, Joya Sahu, Pierluigi Porcu, Jisun Cha, Wenyin Shi, Neda Nikbakht, Megan O'Donnell, Seyfettin Onder Alpdogan, Saritha Kartan
Publikováno v:
Journal of the American Academy of Dermatology. 84:615-623
Background Topical corticosteroids alone or in combination with other therapies are widely used to treat mycosis fungoides (MF), but data on response rates to their use as monotherapy in MF are limited. Objective To evaluate the efficacy of topical c
Publikováno v:
Leuk Lymphoma
Treatment-specific responses and comprehensive disease characteristics are limited in black patients with cutaneous T-cell lymphoma (CTCL). These shortcomings prompted us to perform a subgroup analysis of black patients enrolled in the MAVORIC trial
Autor:
Sushil Ghimire, Joanne Filicko-O'Hara, S. Onder Alpdogan, John L. Wagner, Matthew Carabasi, Sameh Gaballa, Michael Ramirez, Mark Weiss, Andrew E. Chapman, Jerald Z. Gong, Pierluigi Porcu, Jonathan Pan, Barbara Pro, Lewis J. Rose, Martina DiMeglio, Ubaldo E. Martinez-Outschoorn, Neal Flomenberg
Publikováno v:
Leukemia & Lymphoma. 62:590-597
We developed an outpatient salvage chemotherapy regimen using bendamustine, ofatumumab, carboplatin and etoposide (BOCE) to treat relapsed/refractory non-Hodgkin lymphoma (RR NHL) in a single-center phase I/II study. Primary objectives were safety, t
Autor:
Pierluigi Porcu, Neil Palmisiano, Dolores Grosso, Joanne Filicko-O'Hara, Thomas R. Klumpp, Ubaldo E. Martinez-Outschoorn, John L. Wagner, Matthew Carabasi, Usama Gergis, Shannon Rudolph, Maria Werner-Wasik, Neal Flomenberg, William O'Hara, Margaret Kasner, Lindsay Wilde, Wenyin Shi, Beth W. Colombe, Adam F. Binder, Michael Sun, Onder Alpdogan
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1861-1867
The use of cyclophosphamide (CY) for bidirectional tolerization of recipient and donor T cells is associated with reduced rates of graft-versus-host disease (GVHD) and nonrelapse mortality (NRM) after HLA-matched hematopoietic stem cell transplantati
Autor:
Tingting Zhan, Megan O'Donnell, Pierluigi Porcu, Onder Alpdogan, Wenyin Shi, Saritha Kartan, Neda Nikbakht, Romsin Zaya, Doaa Shalabi
Publikováno v:
Journal of Dermatological Science. 98:98-101
Background Questionnaire tools are increasingly being used to assess health related quality of life (HRQOL) in mycosis fungoides (MF) patients. However, a thorough understanding of the factors that lead to poor HRQoL in early stage disease and their
Autor:
Pamela Heeter, Erika Cavallone, Frank McCormick, Lawrence K. Kaplan, Laura B. Pincus, Wade Berry, Basem M. William, Aaron Zhan, Khoan Vu, Jonathan E. Brammer, Chen-Yen Yang, Charalambos Andreadis, Matthew J. Wieduwilt, Pierluigi Porcu, Weiyun Z. Ai, Chi-Heng Wu
Publikováno v:
Clinical Cancer Research. 26:1000-1008
Purpose: The histone deacetylase (HDAC) inhibitor romidepsin and the anthracycline liposomal doxorubicin (LD) have modest single-agent activity in cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). We investigated the safety and
Autor:
Michael Chang, Pierluigi Porcu, Li-Anne S Lim, Arman Mashayekhi, Lauren A Dalvin, Nina L. Martinez, Mehdi Mazloumi, Carol L. Shields, David Ancona-Lezama, Jon Glass
Publikováno v:
Asia-Pacific Journal of Ophthalmology. 9:110-116
Purpose The aim of this study was to identify clinical factors predictive of time to central nervous system (CNS) lymphoma or death in patients with vitreoretinal lymphoma (VRL). Design Retrospective cohort study. Methods Patients with VRL (n = 95 pa
Autor:
Chris Karlovich, Richard Shine, Jennifer H. Yearley, Martin A. Cheever, Pierluigi Porcu, Francine M. Foss, Steven M. Horwitz, Youn H. Kim, Alison J. Moskowitz, Michael S. Khodadoust, Wendy M. Blumenschein, P. Mickey Williams, Andrei R. Shustov, Vivekananda Datta, Erin Cantu, Biswajit Das, Lubomir Sokol, Yi Yang, Sophia Fong, Holden T. Maecker, Shufeng Li, Priyanka B. Subrahmanyam, Nirasha Ramchurren, Alain H. Rook, Elad Sharon, Satish Shanbhag, Jinah Kim, Robert H. Pierce, Steven P. Fling, Holbrook E Kohrt, Asa Davis, Justine N. McCutcheon, Rajesh Patidar
Publikováno v:
J Clin Oncol
PURPOSE To assess the efficacy of pembrolizumab in patients with advanced relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS). PATIENTS AND METHODS CITN-10 is a single-arm, multicenter phase II trial of 24 patients with advanced MF